NDC 69539-112 – Azacitidine
Azacitidine 100 mg/1 · Injection, Powder, Lyophilized, For Solution · Intravenous, Subcutaneous
Product NDC69539-112
Product details
- Brand name
- Azacitidine
- Generic name
- Azacitidine
- Labeler
- MSN LABORATORIES PRIVATE LIMITED
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous, Subcutaneous
- Marketing category
- ANDA · ANDA212580
- Marketed since
- May 16, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- Nucleoside Metabolic Inhibitor
Active ingredients
- Azacitidine 100 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 69539-112-01 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (69539-112-01) | May 18, 2024 |
Other Azacitidine products
- 16729-306 Azacitidine 100 mg/1 · Injection, Powder, Lyophilized, For Solution · Accord Healthcare Inc.
- 70121-1237 Azacitidine 100 mg/1 · Injection, Powder, Lyophilized, For Solution · Amneal Pharmaceuticals LLC
- 60505-6271 Azacitidine 100 mg/1 · Injection, Powder, Lyophilized, For Solution · Apotex Corp
- 72485-201 Azacitidine 100 mg/1 · Injection, Powder, Lyophilized, For Solution · Armas Pharmaceuticals Inc.
- 68001-313 Azacitidine 100 mg/1 · Injection, Powder, Lyophilized, For Solution · BluePoint Laboratories
- 68001-527 Azacitidine 100 mg/1 · Injection, Powder, Lyophilized, For Solution · BluePoint Laboratories
- 68001-620 Azacitidine 100 mg/1 · Injection, Powder, Lyophilized, For Solution · BluePoint Laboratories.
- 31722-365 Azacitidine 100 mg/1 · Injection, Powder, Lyophilized, For Solution · Camber Pharmaceuticals, Inc.
- 72572-020 Azacitidine 100 mg/1 · Injection, Powder, Lyophilized, For Solution · Civica, Inc.
- 43598-305 Azacitidine 100 mg/1 · Injection, Powder, Lyophilized, For Solution · Dr. Reddy's Laboratories Inc.
- 43598-465 Azacitidine 100 mg/1 · Injection, Powder, Lyophilized, For Solution · Dr. Reddy's Laboratories Inc.
- 43598-678 Azacitidine 100 mg/1 · Injection, Powder, Lyophilized, For Solution · Dr. Reddy's Laboratories Inc.